Bausch Health Companies (BHC) is identified as a ridiculously cheap stock with promising growth potential.

From Yahoo Finance: 2025-04-19 15:47:00

In a list of 11 ridiculously cheap stocks to invest in, Bausch Health Companies Inc. (NYSE:BHC) stands out. The company is dedicated to becoming a globally integrated healthcare company, focusing on various segments like GI, hepatology, and dermatology. With a forward P/E of 1.04, BHC presents a compelling opportunity for investors.

Bausch Health Companies (BHC) is strategically positioned in the mental health market, with a chance to revolutionize the treatment of TRD, a $3 billion market. Despite financial challenges, the company’s repositioning of Aplenzin for TRD treatment shows promise for both clinical and financial success, boosting revenues and value.

Management is optimistic about Bausch Health Companies Inc. (BHC), with revenue guidance between $4.95 billion and $5.1 billion. The company is focusing on growth through innovation, including the RED-C program and the Next Generation Fraxel device. BHC ranks as the top ridiculously cheap stock to invest in, with strong potential for growth and returns.



Read more at Yahoo Finance: Is Bausch Health Companies (BHC) the Ridiculously Cheap Stock to Invest in?